Vulvar biopsy: Punch biopsy or cervical forceps biopsy?

Biopsy Cancer Gynecology Punch biopsy Surgery Vulva

Journal

Journal of gynecology obstetrics and human reproduction
ISSN: 2468-7847
Titre abrégé: J Gynecol Obstet Hum Reprod
Pays: France
ID NLM: 101701588

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 03 08 2023
accepted: 12 09 2023
pubmed: 15 9 2023
medline: 15 9 2023
entrez: 14 9 2023
Statut: ppublish

Résumé

The primary objective of our study is to investigate the rate of non-contributory biopsies between punch biopsy(PB) and cervical forceps biopsy(CFB) for a vulvar lesion seen in consultation. The secondary objective of our study is to evaluate the rate of underestimation of a more severe lesion for patients who have undergone vulvar excision. This is a retrospective, descriptive, and comparative study conducted at three centers. The study population consisted of patients who underwent vulvar biopsy between 2017 and 2022 in a gynecological surgery consultation at two French hospitals, as well as a city office. The biopsy techniques used were punch or cervical forceps biopsy. Quantitative variables were analyzed using the Mann-Whitney test, while Pearson's or Fisher's Xi2 tests were used for qualitative variables. The significance level was set at 5%. We conducted a retrospective study of 179 vulvar biopsies, of which 100 were punch biopsies and 79 were cervical forceps biopsies, from a total of 107 patients. There was no significant difference in the rate of non-contributory biopsies between the PB and CB groups (p = 1). When analyzing the secondary endpoint of our study, which included 68 patients who underwent vulvectomy after vulvar biopsy, we found that 66 patients (97%) had a good correlation between the pathology of the vulvar biopsy and that of the vulvectomy specimen. Vulvar biopsy techniques using punch or cervical forceps appear to have similar diagnostic performance and are associated with comparable and low rates of underestimation of invasive lesions.

Identifiants

pubmed: 37709202
pii: S2468-7847(23)00134-4
doi: 10.1016/j.jogoh.2023.102667
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102667

Informations de copyright

Copyright © 2023. Published by Elsevier Masson SAS.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None

Auteurs

Anthony Tuil (A)

Department of Gynecological and Breast Surgery and Oncology, Pitié-Salpêtrière, Assistance Publique des Hôpitaux de Paris (AP-HP), University Hospital, 26 rue Lazare Carnot, Paris 75013, France. Electronic address: Anthonytuil@hotmail.fr.

Christine Bergeron (C)

CerbaPath, Paris, France.

Justine Varinot Lucet (JV)

Service d'anatomie et de Cytologie Pathologiques, Hôspital Tenon, AP-HP, Paris, France.

Yohann Dabi (Y)

Department of Gynaecology, Tenon Hospital, Paris, France.

Amélia Favier (A)

Department of Gynaecology, Tenon Hospital, Paris, France.

Elisabeth Da Maia (E)

Service d'anatomie et de cytologie pathologiques, Pitié-Salpêtrière, AP-HP, Paris, France.

Catherine Uzan (C)

Department of Gynecological and Breast Surgery and Oncology, Pitié-Salpêtrière, Assistance Publique des Hôpitaux de Paris (AP-HP), University Hospital, 26 rue Lazare Carnot, Paris 75013, France; Centre de Recherche Saint-Antoine (CRSA), INSERM UMR_S_938, Cancer Biology and Therapeutics, Sorbonne University, Paris 75012, France; University Institute of Cancer, Sorbonne University, Paris 75013, France.

Jean-Luc Mergui (JL)

Department of Gynecological and Breast Surgery and Oncology, Pitié-Salpêtrière, Assistance Publique des Hôpitaux de Paris (AP-HP), University Hospital, 26 rue Lazare Carnot, Paris 75013, France.

Geoffroy Canlorbe (G)

Department of Gynecological and Breast Surgery and Oncology, Pitié-Salpêtrière, Assistance Publique des Hôpitaux de Paris (AP-HP), University Hospital, 26 rue Lazare Carnot, Paris 75013, France; Centre de Recherche Saint-Antoine (CRSA), INSERM UMR_S_938, Cancer Biology and Therapeutics, Sorbonne University, Paris 75012, France; University Institute of Cancer, Sorbonne University, Paris 75013, France.

Classifications MeSH